Research Highlights: In a Phase 1, first-in-human trial, a one-time infusion of an investigational CRISPR-Cas9 therapy targeting angiopoietin-like protein 3 (ANGPTL3) was safe and reduced LDL cholesterol by nearly 50% and reduced triglycerides by...
The US is an exception but generally, the cost of therapies becomes commercially viable with the passage of time.
For example, our 2 year old daughter just had her DNA profiled because she has a few manageable, yet ongoing developmental deficiencies. Her DNA markers will guide her treatment.
When I was a child this type of treatment was sci-fi, and when it was invented you could have said “by rich for rich” or whatever.
For rich by rich, only rich get.
Thats not really true.
The US is an exception but generally, the cost of therapies becomes commercially viable with the passage of time.
For example, our 2 year old daughter just had her DNA profiled because she has a few manageable, yet ongoing developmental deficiencies. Her DNA markers will guide her treatment.
When I was a child this type of treatment was sci-fi, and when it was invented you could have said “by rich for rich” or whatever.
Cost and price are two different things. Insulin is cheap to make but people die from not being able to afford the sticker price.
… In the US, yes
Not outside the US